JAK2 and Thrombocytosis: Since cases with thrombocytosis were assessed only in terms of the frequency of JAK-2 mutation in that study and the frequencies were found to be different from those in other studies that assessed the frequency of JAK-2 mutation in cases with BCR‐ABL‐negative CMDs (12, 17).